EDAP TMS Reports 26% Revenue Growth in Q3 2026 Driven by Focal One System Sales
EDAP TMS (FOCL) reported third-quarter revenue of $9.8 million, representing a 26% year-over-year increase. This growth was primarily fueled by the sales of its Focal One systems and a 24% rise in treatment-driven revenue. Notably, U.S. procedure volume surged by 32%, significantly outpacing the previous year's growth rate. Despite strong operational metrics and an improved gross margin of 51.4%, the company reported a net loss of $4.5 million ($0.10 per share). Management attributed some revenue timing challenges to longer hospital committee approval processes and seasonal procurement delays, which shifted certain capital sales into the fourth quarter. The company maintains a solid cash position of $56.3 million following a recent equity offering.
Topics: Financial Guidance Gross Margin Improvement Operating Loss Revenue Growth